Evidence links microglia to facilitating AD pathology, as IGF1 expression, implicated in regulating neurogenesis, increases in APP/PS1 mice along with increased microglial activation and reduced SGZ neurogenesis (Myhre et al., 2019). The gene discussed is IGF1; the disease is Alzheimer disease.